Derivation and Validation of a Screening Model for Hypertrophic Cardiomyopathy Based on Electrocardiogram Features

BACKGROUND: Hypertrophic cardiomyopathy (HCM) is a widely distributed, but clinically heterogeneous genetic heart disease, affects approximately 20 million people worldwide. Nowadays, HCM is treatable with the advancement of medical interventions. However, due to occult clinical presentations and a...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Lanyan, Gao, Chao, Yang, Weiping, Ma, Zhiling, Zhou, Mengyao, Liu, Jianzheng, Shao, Hong, Wang, Bo, Hu, Guangyu, Zhao, Hang, Zhang, Ling, Guo, Xiong, Huang, Chong, Cui, Zhe, Song, Dandan, Sun, Fangfang, Liu, Liwen, Zhang, Fuyang, Tao, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170889/
https://www.ncbi.nlm.nih.gov/pubmed/35686042
http://dx.doi.org/10.3389/fcvm.2022.889523

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170889/
https://www.ncbi.nlm.nih.gov/pubmed/35686042
http://dx.doi.org/10.3389/fcvm.2022.889523

Ejemplares similares